+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Next-generation Sequencing Library Preparation - Global Strategic Business Report 2026

  • PDF Icon

    Report

  • 220 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6068576
The global market for Next-generation Sequencing Library Preparation was valued at US$1.7 Billion in 2025 and is projected to reach US$4.3 Billion by 2032, growing at a CAGR of 13.9% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Next-Generation Sequencing Library Preparation Market - Key Trends & Drivers SummarizedHow Is Next-Generation Sequencing Library Preparation Advancing Genomic Research?

Next-generation sequencing (NGS) library preparation is a critical step in genomic analysis, enabling researchers to convert DNA and RNA samples into formats suitable for high-throughput sequencing. The preparation process involves fragmentation, adapter ligation, amplification, and quality control, ensuring accurate and efficient sequencing. NGS technology has revolutionized genetics, allowing for faster and more cost-effective analysis of genomes, transcriptomes, and epigenomes across various applications, including precision medicine, oncology, infectious disease research, and agricultural genomics. The increasing adoption of NGS in clinical diagnostics is driving demand for more streamlined, automation-friendly, and scalable library preparation kits that enhance efficiency and reproducibility. Additionally, advancements in single-cell sequencing and long-read sequencing are pushing the boundaries of genome analysis, necessitating improved library preparation methods tailored for complex samples. As researchers strive for higher sequencing accuracy, sensitivity, and throughput, library preparation technologies continue to evolve, playing a crucial role in advancing the field of genomics.

What Challenges Are Affecting the Adoption of NGS Library Preparation Technologies?

Despite its transformative potential, the NGS library preparation market faces several challenges that impact accessibility, efficiency, and cost-effectiveness. One of the primary concerns is the labor-intensive nature of traditional library preparation methods, which require skilled technicians, expensive reagents, and extensive sample handling. Variability in sample quality and preparation efficiency can lead to sequencing errors and reduced data reliability, necessitating robust quality control measures. Another major challenge is the high cost of library preparation kits, which can be prohibitive for smaller research institutions and clinical laboratories. Additionally, the complexity of handling diverse sample types, including low-input and degraded DNA, requires highly specialized protocols, increasing the need for customized solutions. Regulatory challenges and standardization issues further hinder clinical adoption, as laboratories must adhere to stringent compliance requirements for NGS-based diagnostics. Overcoming these challenges will require continued innovation in automation, reagent chemistry, and bioinformatics solutions to make NGS library preparation more efficient, cost-effective, and scalable for a wider range of applications.

How Are Innovations Driving the Future of NGS Library Preparation?

Technological advancements are significantly improving the efficiency and accuracy of NGS library preparation, addressing key challenges in sample processing and sequencing quality. One of the most impactful innovations is the automation of library preparation workflows, reducing hands-on time, minimizing human error, and increasing sample throughput. Robotic liquid handling systems and microfluidic platforms are streamlining the preparation process, making high-throughput sequencing more accessible to clinical and research laboratories. The development of transposase-based library preparation methods, such as Illumina’s Nextera technology, is simplifying DNA fragmentation and adapter insertion, reducing preparation time and reagent costs. Additionally, single-tube and direct RNA sequencing approaches are eliminating the need for complex workflows, improving efficiency in transcriptomics studies. Advances in molecular barcoding and unique molecular identifiers (UMIs) are enhancing sequencing accuracy by reducing PCR bias and detecting low-frequency variants. The integration of AI and machine learning in bioinformatics is also optimizing library preparation protocols by predicting optimal reagent conditions and improving data interpretation. As these innovations continue to evolve, the NGS library preparation market is poised for greater efficiency, scalability, and clinical adoption.

What Is Driving the Growth of the NGS Library Preparation Market?

The growth in the next-generation sequencing library preparation market is driven by several factors, including increasing demand for personalized medicine, expanding applications of NGS in disease research, and technological advancements in automation and reagent chemistry. The growing adoption of NGS-based diagnostics in oncology, infectious diseases, and rare genetic disorders is fueling demand for more efficient and cost-effective library preparation solutions. The rise of single-cell sequencing is also contributing to market growth, as researchers require specialized library preparation methods to analyze individual cells with high sensitivity. Additionally, the expansion of agricultural genomics, microbiome studies, and synthetic biology is further driving market demand, as these fields rely on high-throughput sequencing for genomic analysis. The push for standardization and regulatory approvals for clinical NGS applications is also shaping market trends, with manufacturers developing compliant library preparation kits that meet stringent diagnostic requirements. Investments in bioinformatics and cloud-based sequencing platforms are enhancing data management and accessibility, making NGS more widely available for diverse research and clinical applications. As advancements in sequencing technologies continue to lower costs and improve accuracy, the NGS library preparation market is expected to witness sustained growth, revolutionizing genomic research and precision medicine.

Report Scope

The report analyzes the Next-generation Sequencing Library Preparation market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Targeted Genome Sequencing segment, which is expected to reach US$1.4 Billion by 2032 with a CAGR of a 10.9%. The Whole Genome Sequencing segment is also set to grow at 16.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $503.5 Million in 2025, and China, forecasted to grow at an impressive 13.4% CAGR to reach $750.9 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Next-generation Sequencing Library Preparation Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Next-generation Sequencing Library Preparation Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Next-generation Sequencing Library Preparation Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Agilent Technologies, Inc., Alida Biosciences, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Next-generation Sequencing Library Preparation market report include:

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Next-generation Sequencing Library Preparation - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Surge in Precision Medicine Initiatives Throws the Spotlight on Customized NGS Library Preparation Solutions
  • Rapid Growth of Clinical Diagnostics Strengthens Business Case for Automation in Library Preparation Workflows
  • Increasing Focus on Genomic Surveillance Accelerates Demand for High-Throughput NGS Library Prep Kits
  • Rising Investments in Cancer Genomics Propels Growth of Targeted Sequencing Library Preparation Products
  • Expansion of Population Genomics Programs Expands Addressable Market Opportunity for Large-Scale Library Prep Platforms
  • Adoption of AI and Machine Learning in Genomic Data Analysis Spurs Demand for Standardized, High-Quality Library Prep Methods
  • Growing Use of Liquid Biopsy Technologies Drives Adoption of Ultra-Sensitive Library Preparation Protocols
  • Regulatory Push for Validated and Reproducible Clinical Assays Strengthens Business Case for Commercial NGS Library Kits
  • Integration of Automation and Robotics in Lab Workflows Drives Efficiency and Reduces Human Error in Library Preparation
  • Increasing Demand for Decentralized Testing Models Spurs Development of Point-of-Care Compatible Library Prep Technologies
  • Rising Demand for Epigenetic and Transcriptomic Studies Expands Scope for Specialized Library Preparation Solutions
  • Advancements in Long-Read Sequencing Technologies Drives Innovation in Compatible Library Preparation Reagents
  • Continuous Decline in Sequencing Costs Sustains Growth Momentum Across Research and Clinical Applications
  • Strategic Collaborations Between Pharma and Genomics Firms Fuel Adoption of Scalable NGS Library Preparation Platforms
  • Expansion of Biobanking and Genomic Data Repositories Generates Long-Term Demand for Reliable Library Prep Protocols
  • Transition to Cloud-Based Genomics Workflows Spurs Demand for Seamlessly Integratable Library Prep Solutions
  • Emphasis on Quality Control and Standardization Across Labs Strengthens Need for Pre-Validated Library Prep Kits
  • Accelerating Adoption of NGS in Agriculture and Microbiome Research Opens New Market Avenues for Library Preparation Products
  • Government Funding Initiatives and Genomics-Focused National Programs Drive Regional Market Penetration and Adoption
  • Intensifying Competitive Landscape Spurs Innovation in Fast, Cost-Effective, and Scalable Library Preparation Technologies
  • Emergence of Single-Cell Sequencing Drives Demand for Ultra-Low Input and Specialized Library Prep Workflows
  • Growing Importance of Data Privacy and Compliance Creates Challenges in Adoption of Cloud-Linked NGS Prep Systems
  • Movement Toward Personalized Wellness and Preventive Healthcare Expands Market Opportunity for Consumer-Directed Library Prep Solutions
  • Increasing Academia-Industry Collaborations Propels Development of Customizable and Niche Library Preparation Technologies
  • Shift Toward Multiplexed and Multi-Omic Sequencing Accelerates Innovation in Versatile Library Prep Protocols
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Next-generation Sequencing Library Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World 8-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2026 & 2032
  • Table 4: World Recent Past, Current & Future Analysis for Targeted Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 5: World 8-Year Perspective for Targeted Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 6: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 7: World 8-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World 8-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 10: World Recent Past, Current & Future Analysis for Other Sequencing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 11: World 8-Year Perspective for Other Sequencing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 12: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 13: World 8-Year Perspective for Reproductive Health Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World 8-Year Perspective for Infectious Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 16: World Recent Past, Current & Future Analysis for Other Disease Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 17: World 8-Year Perspective for Other Disease Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 18: World Recent Past, Current & Future Analysis for Drug & Biomarker Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 19: World 8-Year Perspective for Drug & Biomarker Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World 8-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 22: World Recent Past, Current & Future Analysis for Cancer Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 23: World 8-Year Perspective for Cancer Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 24: World Recent Past, Current & Future Analysis for Academic & Research Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 25: World 8-Year Perspective for Academic & Research Institutions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: World 8-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 28: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 29: World 8-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 31: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Library Preparation Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 33: World 8-Year Perspective for Library Preparation Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 34: World Recent Past, Current & Future Analysis for Library Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 35: World 8-Year Perspective for Library Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

Table Information